Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 3Other hematologic neoplasm 1

Conditions

Colorectal Neoplasms 1Colonic Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 228Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Niclosamide × Gastrointestinal × Clear all
NCT04296851 2020-03-05

Niclosamide for Familial Adenomatous Polyposis

Yonsei University

Phase 2 Unknown
72 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT02687009 2020-02-19

A Study of Niclosamide in Patients With Resectable Colon Cancer

Duke University

Phase 1 Terminated
1 enrolled
Gastrointestinal

Colonic Neoplasms

NCT02519582 2018-09-12

Nikolo

Charite University, Berlin, Germany

Phase 2 Unknown
37 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡